A commonly used antibiotic can be modified to eliminate the risk that it will cause hearing loss, a study in mice has demonstrated. The newly patented antibiotic, N1MS, cured urinary tract infection in mice just as well as sisomcicin, but did not cause deafness, study results show. The study presents a promising new approach to generating a new class of novel, nontoxic antibiotics, researchers say.